Skip to content

Transversus Abdominis Plane Block (TAP) Versus Thoracoabdominal Nerve Block Through Perichondrial Approach (M-TAPA) in Laparoscopic Gynecologic Surgeries

Transversus Abdominis Plane Block (TAP) Versus Thoracoabdominal Nerve Block Through Perichondrial Approach (M-TAPA) in Laparoscopic Gynecologic Surgeries

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06995404
Enrollment
90
Registered
2025-05-29
Start date
2025-05-30
Completion date
2025-06-30
Last updated
2025-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic Laparoscopic Surgery, Regional Anesthesia Block

Brief summary

Although laparoscopic techniques are considered minimally invasive surgical procedures with lower perioperative pain scores compared to open surgeries, they are still associated with significant levels of pain. This study aims to investigate the analgesic effectiveness of two routinely performed regional analgesic techniques in our clinic-ultrasound-guided classic bilateral TAP block and ultrasound-guided bilateral M-TAPA block-in patients undergoing laparoscopic gyneco-oncologic surgery (LGOS), as well as their effects on intraoperative opioid consumption.

Interventions

Patients in the TAP group will receive a bilateral Transversus Abdominis Plane (TAP) block under ultrasound guidance prior to surgery after general anaesthesia, with the local anesthetic administered between the internal oblique and transversus abdominis muscles. A total of 40 mL of 0.25% bupivacaine will be used for the procedure.

Patients in the M-TAPA group will receive a bilateral Thoracoabdominal Nerve Block through Perichondrial Approach (M-TAPA) under ultrasound guidance prior to surgery after general anaesthesia. A total of 40 mL of 0.25% bupivacaine will be used for the procedure.

Sponsors

Ankara Etlik City Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Female patients aged between 18 and 80 years, classified as ASA physical status I to III, undergoing laparoscopic gynecologic surgery under general anesthesia -

Exclusion criteria

Coagulopathy Neuropathy Chronic analgesic therapy Severe cardiopulmonary disease Uncontrolled diabetes mellitus (HbA1c \> 8%) Severe renal or hepatic failure Pregnancy or lactation Body mass index (BMI) greater than 35 kg/m² Local infection at the injection site Inability to comprehend pain scores or cooperate (e.g., Alzheimer's disease, mental retardation) Allergy to local anesthetic agents Refusal to participate in the study \-

Design outcomes

Primary

MeasureTime frame
Evaluation of intraoperative opioid consumptionduring surgery

Secondary

MeasureTime frameDescription
Comparison of postoperative Visual Analog Scale (VAS) pain scorespostoperative first dayVAS is an eleven-scale pain score scored from 0 to 10, with vas 0 being no pain and vas 10 being maximum pain.

Countries

Turkey (Türkiye)

Contacts

Primary ContactELA ERDEM HIDIROGLU
drelaerdem@gmail.com03127970000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026